The Evaluation of Laser Lancing Devices in Adult Type 2 Diabetes Patients

NAUnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 10, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

December 31, 2022

Conditions
Type 2 Diabetes
Interventions
DEVICE

laser lancing device or lancet for blood glucose level measurement

Subjects measure blood glucose level using laser lancing device (LMT-1000) and lancet for 2 months each.

Trial Locations (1)

08308

RECRUITING

Korea University medical center, Seoul

Sponsors
All Listed Sponsors
collaborator

Korea Medical Device Development Fund

UNKNOWN

lead

Korea University Guro Hospital

OTHER

NCT05251506 - The Evaluation of Laser Lancing Devices in Adult Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter